Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SciSparc to Commence Pre-Clinical Study Using CBD-Based Treatment for Epilepsy

americanpharmaceuticalreviewMarch 16, 2021

Tag: SciSparc , Sheba , CBD , Epilepsy , SCI-210

PharmaSources Customer Service